Michael Rapp - Net Worth and Insider Trading
Michael Rapp Net Worth
The estimated net worth of Michael Rapp is at least $10 Million dollars as of 2025-04-25. Michael Rapp is the Director of Immunome Inc and owns about 1,008,608 shares of Immunome Inc (IMNM) stock worth over $8 Million. Michael Rapp is also the 10% Owner of Zynerba Pharmaceuticals Inc and owns about 1,500,000 shares of Zynerba Pharmaceuticals Inc (ZYNE) stock worth over $2 Million. Details can be seen in Michael Rapp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Rapp has not made any transactions after 2021-09-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael Rapp
Michael Rapp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Rapp owns 4 companies in total, including Immunome Inc (IMNM) , Zynerba Pharmaceuticals Inc (ZYNE) , and The One Group Hospitality Inc (STKS) among others .
Click here to see the complete history of Michael Rapp’s form 4 insider trades.
Insider Ownership Summary of Michael Rapp
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| IMNM | Immunome Inc | 2021-09-13 | director & 10 percent owner |
| ZYNE | Zynerba Pharmaceuticals Inc | 2018-05-30 | 10 percent owner |
| STKS | The One Group Hospitality Inc | 2007-07-13 | director & 10 percent owner & President |
 | | 2007-07-13 | director & 10 percent owner & President |
Michael Rapp Latest Holdings Summary
Michael Rapp currently owns a total of 2 stocks. Among these stocks, Michael Rapp owns 1,008,608 shares of Immunome Inc (IMNM) as of September 13, 2021, with a value of $8 Million and a weighting of 81.27%. Michael Rapp also owns 1,500,000 shares of Zynerba Pharmaceuticals Inc (ZYNE) as of May 30, 2018, with a value of $2 Million and a weighting of 18.73%.
Latest Holdings of Michael Rapp
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| IMNM | Immunome Inc | 2021-09-13 | 1,008,608 | 8.39 | 8,462,221 |
| ZYNE | Zynerba Pharmaceuticals Inc | 2018-05-30 | 1,500,000 | 1.30 | 1,950,000 |
Holding Weightings of Michael Rapp
Michael Rapp Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Rapp has made a total of 4 transactions in Immunome Inc (IMNM) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Immunome Inc is the acquisition of 25,962 shares on September 13, 2021, which cost Michael Rapp around $518,202.
According to the SEC Form 4 filings, Michael Rapp has made a total of 0 transactions in Zynerba Pharmaceuticals Inc (ZYNE) over the past 5 years. The most-recent trade in Zynerba Pharmaceuticals Inc is the acquisition of 5,885 shares on May 30, 2018, which cost Michael Rapp around $61,498.
Insider Trading History of Michael Rapp
- 1
Michael Rapp Trading Performance
GuruFocus tracks the stock performance after each of Michael Rapp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Rapp is -12.28%. GuruFocus also compares Michael Rapp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Rapp within 3 months outperforms 3 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael Rapp's insider trading performs compared to the benchmark.
Performance of Michael Rapp
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.68 | | | | | |
| Relative Return to S&P 500(%) | 0.39 | | | | | |
Michael Rapp Ownership Network
Ownership Network List of Michael Rapp
Ownership Network Relation of Michael Rapp
Michael Rapp Owned Company Details
What does Immunome Inc do?
Who are the key executives at Immunome Inc?
Michael Rapp is the director & 10 percent owner of Immunome Inc. Other key executives at Immunome Inc include director & President and CEO Clay B Siegall , Chief Medical Officer Robert Lechleider , and SVP Operations Max Rosett .
Immunome Inc (IMNM) Insider Trades Summary
Over the past 18 months, Michael Rapp made no insider transaction in Immunome Inc (IMNM). Other recent insider transactions involving Immunome Inc (IMNM) include a net purchase of 487,100 shares made by Clay B Siegall , a net purchase of 23,800 shares made by Jean Jacques Bienaime , and a net purchase of 33,300 shares made by .
In summary, during the past 3 months, insiders sold 0 shares of Immunome Inc (IMNM) in total and bought 314,200 shares, with a net purchase of 314,200 shares. During the past 18 months, 17,904 shares of Immunome Inc (IMNM) were sold and 560,005 shares were bought by its insiders, resulting in a net purchase of 542,101 shares.
Immunome Inc (IMNM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Immunome Inc Insider Transactions
Michael Rapp Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Rapp. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Michael Rapp's mailing address is: New York Ny 10019.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
